Gastroenterology

Journal

Publication Venue For

  • Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.  159:306-319.e12. 2020
  • The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.  157:1646-1659.e11. 2019
  • On The Hot Seat: A Rare Cause of Rectal Pain.  157:942-943. 2019
  • An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis.  156:1027-1040.e3. 2019
  • NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.  155:880-891.e8. 2018
  • A Rare Cause of Recurrent Abdominal Pain and Diarrhea.  155:e11-e12. 2018
  • Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.  155:33-37.e6. 2018
  • 809 - Epithelial-Specific P85α KO Enhances Crypt Resilience to Radiation Injury.  154:S-166. 2018
  • Just the FRAX: Management of Glucocorticoid-Induced Osteoporosis.  154:748-750. 2018
  • Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.  153:1260-1272.e3. 2017
  • A Rare Gastrointestinal Presentation in an HIV-Infected Patient.  152:e7-e9. 2017
  • Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.  152:1055-1067.e3. 2017
  • Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.  152:911-912. 2017
  • Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease.  151:1061-1062. 2016
  • Abdominal Pain With an Unusual Radiographic Image.  151:241-242. 2016
  • Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients with Cirrhosis and Hepatorenal Syndrome Type 1.  150:1579-1589.e2. 2016
  • Nuclear Localization of DNAJB6 Is Associated with Survival of Patients with Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.  149:1825-1836.e5. 2015
  • An Enlarging Liver in a Young Diabetic Male.  149:e8-e10. 2015
  • Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans.  149:1575-1586. 2015
  • Identification of risk loci for crohn's disease phenotypes using a genome-wide association study.  148:794-805. 2015
  • A rare case of chronic diarrhea.  148:510-512. 2015
  • A new meaning to butterflies in the stomach.  148:e12-e13. 2015
  • Su1992 TNF Mediates β-Catenin Activation in Intestinal Stem Cells During Colitis.  146:S-516. 2014
  • Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis.  147. 2014
  • An unusual familial, recurrent neoplasm.  146. 2014
  • Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice.  146. 2014
  • Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of crohn's disease.  146:200-209. 2014
  • Reply.  146:320. 2014
  • Tu1573 A Comparative Analysis of Plastic Versus Metal Endoscopic Biliary Stents in Borderline Resectable Pancreatic Cancer Patients Undergoing Extended Neoadjuvant Chemotherapy.  144:S-1129. 2013
  • A most unusual passage per rectum.  144:e3. 2013
  • Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial.  145. 2013
  • How to value technological innovation: A proposal for determining relative clinical value.  144:5-8. 2013
  • Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3′,5′- monophosphate.  145. 2013
  • Second opinion.  145. 2013
  • 177 The Roles of TNFR Signaling and NOX1 in Epithelial ß-Catenin Activation During Colitis.  142:S-44. 2012
  • Tu2049 Use the Duodenum, It's Already There: A Retrospective Cohort Study Comparing Biliary Reconstruction to the Either the Jejunum or Duodenum.  142:S-1105. 2012
  • Endoscopic therapy for sphincter of oddi dysfunction in idiopathic pancreatitis: From empiric to scientific.  143:1423-1426. 2012
  • Hepatitis C virus infects the endothelial cells of the blood-brain barrier.  142:634-643.e6. 2012
  • Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.  140. 2011
  • IL-12 converts Foxp3(+) regulatory T cells to Foxp3(+)IFN-γ(+) T cells with inhibitory functions during induction of colitis.  140:2031-43. 2011
  • Interleukin-12 converts Foxp3+ regulatory T cells to interferonγ-producing Foxp3+ T cells that inhibit colitis.  140:2031-2043. 2011
  • Stromal regulation of human gastric dendritic cells restricts the Th1 response to helicobacter pylori.  141:929-938. 2011
  • TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine.  140:242-253. 2011
  • Phosphoinositide 3-Kinase Signaling Mediates β-Catenin Activation in Intestinal Epithelial Stem and Progenitor Cells in Colitis.  139:869-881.e9. 2010
  • Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative Colitis.  138:595-605.e3. 2010
  • Abdominal pain in a young man with severe hypertension.  139. 2010
  • Antimetastatic Role of Smad4 Signaling in Colorectal Cancer.  138. 2010
  • Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer.  138:958-968. 2010
  • Laparoscopy Improves Short-term Outcomes After Surgery for Diverticular Disease.  138. 2010
  • State of Research in Pediatric Gastroenterology, Hepatology, and Nutrition: 2010 and Beyond.  138. 2010
  • Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.  139:598-608. 2010
  • Endoscopist-Directed Administration of Propofol: A Worldwide Safety Experience.  137:1229-1237. 2009
  • Fecal Incontinence in US Adults: Epidemiology and Risk Factors.  137. 2009
  • Heat Shock Protein 70 Inhibits Apoptosis in Cancer Cells Through Simultaneous and Independent Mechanisms.  136:1772-1782. 2009
  • High Detection Rates of Colorectal Neoplasia by Stool DNA Testing With a Novel Digital Melt Curve Assay.  136:459-470. 2009
  • Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome.  136:1070-1080. 2009
  • Helicobacter pylori Gastritis in Children Is Associated With a Regulatory T-Cell Response.  134:491-499. 2008
  • Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates.  135:1168-1175. 2008
  • Ovalbumin-Protein σ1 M-Cell Targeting Facilitates Oral Tolerance With Reduction of Antigen-Specific CD4+ T Cells.  135:917-925. 2008
  • Response to Ray and Colleagues: The Called-for Large Clinical Trial Is Already Ongoing.  134:370-371. 2008
  • Fenofibrate Represses Interleukin-17 and Interferon-γ Expression and Improves Colitis in Interleukin-10-Deficient Mice.  133:108-123. 2007
  • Monoclonal Anti-Interleukin 23 Reverses Active Colitis in a T Cell-Mediated Model in Mice.  132:2359-2370. 2007
  • Reply.  132:2608-2609. 2007
  • State of Pediatric Gastroenterology, Hepatology, and Nutrition: 2006 and Beyond.  132:434-436. 2007
  • The Genetics of Inflammatory Bowel Disease.  133:1327-1339. 2007
  • A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis.  131:1381-1391. 2006
  • Psychosocial Aspects of the Functional Gastrointestinal Disorders.  130:1447-1458. 2006
  • Tight Mucosal Compartmentation of the Murine Immune Response to Antigens of the Enteric Microbiota.  130:2050-2059. 2006
  • National Institutes of Health Consensus Development Conference statement on Celiac Disease, June 28-30, 2004.  128. 2005
  • Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.  128:2020-2028. 2005
  • Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens.  129:1473-1484. 2005
  • Cholangiocyte endothelin 1 and transforming growth factor β1 production in rat experimental hepatopulmonary syndrome.  129:682-695. 2005
  • Presentation of the Julius M. Friedenwald Medal to Ralph A. Giannella, MD..  128:2152-2157. 2005
  • Behavioral treatment options for urinary incontinence..  126:S82-S89. 2004
  • Predictors of treatment response to behavioral therapy and pharmacotherapy for urinary incontinence..  126:S141-S145. 2004
  • Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer.  125:1203-1218. 2003
  • Cholera toxin adjuvanticity is dependent upon Gm1-mediated NF-κB translocation and activation of dendritic cells.  124:A73-A73. 2003
  • T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice.  124:672-682. 2003
  • Analysis of Pulmonary Heme Oxygenase-1 and Nitric Oxide Synthase Alterations in Experimental Hepatopulmonary Syndrome.  125:1441-1451. 2003
  • An antigen specific colitis model: TNBS (trinitrobenzene sulfonic acid) colitis without EtOH using adoptive T cell transfer.  122:A392-A392. 2002
  • Small intestinal transformation and wasting disease induced in T cell deficient mice by adoptive transfer of CD45RB(Hi) Th2 cells.  122:A73-A73. 2002
  • Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.  123:719-727. 2002
  • Novel genes and functional relationships in the adult mouse gastrointestinal tract identified by microarray analysis.  122:1467-1482. 2002
  • A revisit of the hapten-induced colitis model: Adoptive T cell transfer studies..  120:A193-A193. 2001
  • Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management.  120:607-621. 2001
  • Emerging concepts in the pathophysiology and management of the gastrointestinal manifestations of AIDS.  120:607-21. 2001
  • Identification of a new chloride channel: A sweet story?.  120:299-303. 2001
  • Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent.  121:1191-1202. 2001
  • The requirement for lymphotoxin and Peyer's patches in the development of intestinal lamina propria lymphocytes.  118:A361-A361. 2000
  • American Gastroenterological Association medical position statement: Evaluation and management of occult and obscure gastrointestinal bleeding.  118:197-200. 2000
  • Commensal bacteria as targets in Crohn's disease.  119:254-257. 2000
  • Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.  119:724-733. 2000
  • Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease.  119:1473-1482. 2000
  • Our new president-ralph A. Giannella, M.D.  116:1238-1243. 1999
  • Gastroenterology fellowship training: A generation lost [3].  116:228. 1999
  • Intestinal macrophages display reduced permissiveness to human immunodeficiency virus i and decreased surface CCR5.  116:1043-1053. 1999
  • Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention.  117:388-394. 1999
  • Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16.  115:1062-1065. 1998
  • High mucosal levels of tumor necrosis factor α messenger RNA in AIDS- associated cytomegalovirus-induced esophagitis.  114:77-82. 1998
  • Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics.  115:866-873. 1998
  • Regional differences in L-selectin expression in murine intestinal lymphocytes.  114:965-974. 1998
  • Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: A new approach.  114:305-310. 1998
  • A prognostic model for patients with end-stage liver disease.  113:1278-1288. 1997
  • Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis.  112:1078-1086. 1997
  • Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease.  113:383-389. 1997
  • Uroguanylin and guanylin: Distinct but overlapping patterns of messenger RNA expression in mouse intestine.  113:1000-1006. 1997
  • AGA technical review: Malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection.  111:1724-1752. 1996
  • Chronic unexplained diarrhea in human immunodeficiency virus infection: Determination of the best diagnostic approach.  110:30-37. 1996
  • Chronic unexplained diarrhea in human immunodeficiency virus infection: Determination of the best diagnostic approach [3].  111:269-270. 1996
  • Endoscopic therapy for organized pancreatic necrosis.  111:755-764. 1996
  • Factor analysis of gastrointestinal symptoms [5].  110:969-970. 1996
  • Fluconazole compared with endoscopy for human immunodeficiency virus- infected patients with esophageal symptoms.  110:1803-1809. 1996
  • Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production.  111:419-425. 1996
  • Coping with irritable bowel syndrome IBS): Analgesic and other medication use by IBS patients and IBS non-consulter.  108:A577-A577. 1995
  • Experimental models of inflammatory bowel disease.  109:1344-1367. 1995
  • Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.  108:1753-1760. 1995
  • Sexual abuse and gastrointestinal disease.  108:1945-1946. 1995
  • Wherefore art thou guanylin?.  109:2039-2042. 1995
  • FACTOR-ANALYSIS OF GI SYMPTOMS SUPPORTS ROME CRITERIA FOR FUNCTIONAL GI DISORDERS.  106:A589-A589. 1994
  • TNBS-SPECIFIC ORAL TOLERANCE PROTECTS FROM HAPTEN-INDUCED COLITIS.  106:A772-A772. 1994
  • Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.  107:1643-1652. 1994
  • Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.  106:907-915. 1994
  • Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease.  107:61-69. 1994
  • Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice.  107:1726-1735. 1994
  • CYTOKINE SECRETION BY INTRAEPITHELIAL (IEL) AND LAMINA PROPRIA LYMPHOCYTES (LPL) FROM MURINE SMALL-BOWEL (SB) AND LARGE-BOWEL (LB).  104:A780-A780. 1993
  • EMOTIONAL DISTRESS, RELAXATION AND AIR SWALLOWING RATE - A POSSIBLE ETIOLOGIC MECHANISM IN SOME GASTROINTESTINAL DISORDERS.  104:A1035-A1035. 1993
  • FACTOR-ANALYSIS OF BOWEL SYMPTOMS - REPLICATION IN 2045 STUDENTS.  104:A492-A492. 1993
  • Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.  105:1857-1864. 1993
  • Complications of percutaneous liver biopsy in children.  102:629-632. 1992
  • Endoscopy-negative upper gastrointestinal bleeding in a patient with chronic pancreatitis.  102:320-329. 1992
  • Escherichia coli enterotoxin (STa) binds to receptors, stimulates guanyl cyclase, and Impairs absorption in rat colon.  102:816-822. 1992
  • Ischemia/reperfusion-induced feline intestinal dysfunction: Importance of granulocyte recruitment.  103:807-812. 1992
  • Jejunal toxin inactivation regulates susceptibility of the immature rat to STa.  102:1988-1996. 1992
  • Mesenteric vasoconstriction in cardiogenic shock in pigs.  102:1968-1979. 1992
  • Pyostomatitis vegetans and primary sclerosing cholangitis: Markers of inflammatory bowel disease.  103:668-674. 1992
  • Adenovirus colitis in the acquired immunodeficiency syndrome.  100:976-979. 1991
  • High-protein ascites in patients with the acquired immunodeficiency syndrome.  100:745-748. 1991
  • Interleukin-10 and Counting. Selected Summary.  100:1778-80. 1991
  • Interleukin-10 and counting ....  100:1778. 1991
  • Cyclosporine in Crohn's disease-Low doses won't do it.  98:1383-1384. 1990
  • Cyclosporine in Crohn's Disease-- Low Doses Won't Do It. Selected Summary.  98:1383-4. 1990
  • Cytokines can make you sick - or keep you well. Selected Summary..  98:536-8. 1990
  • Cytokines can make you sick-Or keep you well.  98:1095-1096. 1990
  • Cytokines can make you sick-Or keep you well.  98:536-537. 1990
  • Cytomegalovirus-associated acute pancreatic disease in patients with acquired immunodeficiency syndrome. Report of two patients.  99:263-267. 1990
  • Do organ-specific suppressor T cells prevent autoimmune gastritis?.  98:226-229. 1990
  • Primary Biliary Cirrhosis in a Mouse? Selected Summary.  99:1181-3. 1990
  • Primary biliary cirrhosis in a mouse?.  99:1181-1182. 1990
  • Alterations in Serum Immunoglobulin G Subclasses in Patients With-Ulcerative Colitis and Crohn's Disease.  96:764-768. 1989
  • Interleukin-5 stimulates IgA secretion. Selected Summary..  97:946-9. 1989
  • Interleukin-5 stimulates immunoglobulin a secretion.  96:946-947. 1989
  • Specialized receptors for antigens on gut epithelial T cells.  97:1341-1342. 1989
  • Specialized receptors for antigens on gut epithelial T cells. Selected Summary.  97:1341-2. 1989
  • Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children.  94:367-373. 1988
  • Collagen content and types in normal intestine and in the strictures of Crohn's disease.  94:251-65. 1988
  • Collagen content and types in the intestinal strictures of Crohn's disease.  94:257-265. 1988
  • Receptor-mediated binding and uptake of immunoglobulin a by human liver.  94:762-770. 1988
  • Collagen synthesis by human intestinal smooth muscle cells in culture.  92:400-405. 1987
  • Expression of human immunoglobulin G subclasses in inflammatory bowel disease.  93:1127-1129. 1987
  • Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus.  93:21-28. 1987
  • Intestinal immunity and inflammation: Recent progress.  91:746-768. 1986
  • Role of oxygen radicals in ischemia-induced lesions in the cat stomach.  90:362-367. 1986
  • Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine.  90:80-84. 1986
  • Human pancreatic acinar cells: Studies of stimulus-secretion coupling.  89:109-117. 1985
  • Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine.  89:852-857. 1985
  • Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine.  89:6-12. 1985
  • T cell-B cell regulation in the intestinal lamina propria in Crohn's disease.  89:321-327. 1985
  • Hypogammaglobulinemia Due to Abnormal Suppressor T-Cell Activity in Crohn's Disease.  86:569-576. 1984
  • Infectious agents and inflammatory bowel disease.  85:475-476. 1983
  • Use of diuretics in the treatment of cirrhotic ascites.  84:1051-1055. 1983
  • Chronic Giardiasis: Studies on Drug Sensitivity, Toxin Production, and Host Immune Response.  83:797-803. 1982
  • Ischemic injury in the cat small intestine: Role of superoxide radicals.  82:9-15. 1982
  • Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile.  82:184-193. 1982
  • Streptozotocin-induced diabetes stimulates bile salt sulfation in male rats.  82:1013. 1982
  • Treatment of carbon tetrachloride poisoning with hyperbaric oxygen.  82:767-769. 1982
  • Cholesterol feeding does not alter the defective chylomicron remnant (CMR) uptake by Morris hepatoma.  80:1131. 1981
  • Covert suppressor T cells in Crohn's disease.  80:1513-1521. 1981
  • IgG antibody to Giardia lamblia detected by enzyme-linked immunosorbent assay.  80:1476-1480. 1981
  • Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis.  79:242-254. 1980
  • Chronic proctitis in male homosexuals due to lymphogranuloma venereum.  79:563-565. 1980
  • Physical Chemical and Technical Limitations to Intragastric Titration.  76:1025-1034. 1979
  • Utilization of a radioiodinated bile salt for kinetic studies and hepatic scintigraphy. Studies in nonhuman mammals.  76:272-278. 1979
  • Bile acids in portal blood.  74:964-965. 1978
  • Serum disappearance of cholylglycine (CG).  74:1006. 1978
  • Acetylsalicylate hydrolase (esterase) of fundic gastric mucosa.  72. 1977
  • An 125I Radioimmunoassay for Primary Conjugated Bile Salts.  72:305-311. 1977
  • Effect of acetylsalicylic acid on gastric mucosa. II. Mucosal ATP and phosphocreatine content, and salicylate effects on mitochondrial metabolism.  73:995-999. 1977
  • Effect of acetylsalicylic acid on the amphibian gastric mucosa. I. Electrophysiological and permeability changes.  73:785-789. 1977
  • Liver failure with alcoholic like hyaline after jejuno ileal bypass; reversal by parenteral nutrition and reanastomosis.  72. 1977
  • Properties of Gastric Antrum: III. Selectivity and modification of shunt conductance.  72:72-77. 1977
  • Small Intestinal Injury in the Graft Versus Host Reaction: An Innocent Bystander Phenomenon.  72:886-889. 1977
  • The effect of acetylation (AC) status on cholestasis and hepatocellular damage (HCD) in isoniazid (INH) induced liver disease.  72. 1977
  • A primary conjugated bile salt radioimmunoassay using an iodinated bile salt derivative.  70:940. 1976
  • Radioiodinated cholylglycylhistamine: a potentially useful, physiologic hepatic scanning agent.  70:940. 1976
  • Reversal of Growth Arrest in Adolescents with Crohn's Disease After Parenteral Alimentation.  70:1017-1021. 1976
  • Polymicrobial sepsis following endoscopic retrograde cholangiopancreatography.  69:507-510. 1975
  • International Standard Serial Number (issn)

  • 0016-5085
  • Electronic International Standard Serial Number (eissn)

  • 1528-0012